Mechanism of Anti-Cancer in Breast Cancer Cells With HER2 Overexpression by Dietary Supplement of Five Edible Plants
- PMID: 40661803
- PMCID: PMC12256988
- DOI: 10.1002/fsn3.70617
Mechanism of Anti-Cancer in Breast Cancer Cells With HER2 Overexpression by Dietary Supplement of Five Edible Plants
Abstract
Edible plants are known to have many pharmacological properties, including anti-cancer. Mylife/Mylife100, a Thai dietary supplement composed of five types of edible plants (Sesamum indicum L., Psidium guajava L., Centella asiatica (L.) Urb., Glycine max (L.) Merr., and Garcinia mangostana L.) was evaluated for its anti-cancer effect on breast cancer cells with HER2 overexpression (SK-BR-3 cell line). The results demonstrated that the supplement showed cytotoxic activity against SK-BR-3 cell growth in a dose-dependent manner, with an IC50 value of 116.5 ± 2.30 μg/mL. The effect of the supplement on apoptosis induction in SK-BR-3 cells was investigated. The findings revealed that the supplement induced nuclear condensation and loss of mitochondrial membrane potential, both hallmarks of apoptosis. Additionally, the supplement increased the sub-G1 population analyzed by flow cytometry and was further validated by attenuation of anti-apoptotic proteins (Bcl-xL and Mcl-1) and the induction of pro-apoptotic proteins (Bax, cleavage caspase 7 and cleavage PARP). Moreover, the supplement also inhibited the PI3K/Akt pathway and enhanced MAPK signaling pathways. These findings indicated that the Mylife/Mylife100 supplement suppresses cell growth and induces apoptosis via activation of the intrinsic pathway and regulation of the PI3K/Akt and MAPK signaling pathways against SK-BR-3 cells.
Keywords: Mylife/Mylife100 supplement; anti‐cancer; apoptosis; breast cancer cell; five edible plants.
© 2025 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.
Conflict of interest statement
Asian Phytoceuticals Public Company limited provided the Mylife/Mylife100 supplement and has no influence on the study.
Figures







Similar articles
-
Elucidating the Potential of E-cadherin Re-expression along with Trichostatin A and Zebularine in Enhancing Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis in Human Breast Adenocarcinoma Cells.Curr Cancer Drug Targets. 2025 Jun 20. doi: 10.2174/0115680096374361250610075556. Online ahead of print. Curr Cancer Drug Targets. 2025. PMID: 40574394
-
Exploration of Pharmacological Mechanism of Kaempferol in Treating Rheumatoid Arthritis based on Network Pharmacology, Molecular Modelling, and Experimental Validation.Curr Pharm Des. 2025 Jun 30. doi: 10.2174/0113816128357060250611173717. Online ahead of print. Curr Pharm Des. 2025. PMID: 40598731
-
Hsa_circ_0002238 promotes the malignant behavior of colorectal cancer.Front Pharmacol. 2025 Jun 13;16:1541820. doi: 10.3389/fphar.2025.1541820. eCollection 2025. Front Pharmacol. 2025. PMID: 40584619 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Ahmad, A. , Hayat I., Arif S., Masud T., Khalid N., and Ahmed A.. 2014. “Mechanisms Involved in the Therapeutic Effects of Soybean (<styled-content style="fixed-case"> Glycine max </styled-content>).” International Journal of Food Properties 17, no. 6: 1332–1354. 10.1080/10942912.2012.714828. - DOI
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous